Compression therapy is an extremely effective treatment modality, the efficacy of which is frequently underestimated or neglected. There are important areas in medicine in which compression therapy (CT) could be beneficial to patients but is not used because of lack of knowledge of the prescribers. There are countries in which CT has no tradition and is unknown to patients who could profit from it. Only few medical indications for CT are endorsed by evidence based medicine.At the present time it is extremely difficult to convince the vast group of medical people who are not specifically interested or lack knowledge about the merits of good compression, because the arguments in favour of CT are weak, and our standards are vague or non-existent. In addition, patients are often unaware of CT or do not experience the benefits due to poor compliance.As long as we are unable to give the right dosage for the individual patient and as long as we do not agree how this should be measured, then CT will remain an obscure treatment modality, underestimated and underreported.
Meet The Board
Eduardo Da Matta
Although the ICC does not have any regulatory power, proposals elaborated by joint working groups of experts from the medical field and the industry will be able to provide a valuable basis for further improvements of internationally accepted regulations and guidelines. Working groups consisting of medical experts and representatives of the industry are invited to cooperate in the following activities:
Organize meetings in which several problems of common interest to both groups can be discussed
Develop and deliver consensus reports and recommendations
Organize teaching courses on CT
Guidance on experimental and clinical trials
Plan and coordinate effective communication and education
Give recommendations for indications and classification of compression products
U.Meyer - Medi
H.Schepers - Sigvaris
F.Cros - Innothera
F.Girard - Gibaud
E.Gancia - Cizeta
G.Davison - Activa Healthcare
X.Saudez – Pierre Fabre
M.Abel - Lohmann&Rauscher
A.Sidler – Salzmann Medico
R.Convert - Thuasne
T.Schmeltzpfenning - BSN
Wraps are compression devices that appeared in the USA about 20 years ago.They have been the subject of clinical studies for less than 5 years. Several manufacturers have marketed different devices.
A first meeting of a working group on the subject took place in 2019. It enabled a review of available studies and a better understanding of the major clinical indications: venous oedema, venous leg ulcer and lymphedema.
Several other steps could be considered as early as 2021 :
A more accurate definition of a wrap
Clinical recommendations for studying a wrap
Setting up an international monitoring register
A better knowledge of the pressures accepted by the patient according to the pathology.
Will wraps replace bandages by 2030?
The debate is open and goodwill is welcome.
M.Abel - Lohmann&Rauscher
D.Bender - Circaid
Kevin Dierck - BSN
Jeanette Muldoon - Activa Healthcare
Guido Hitschmann - 3M
Reynald Convert - Thuasne
Cyrine Ben Amor - Thuasne
Jens Bichel - 3M
Josip Stojic - KOB
Ferdinand Tamoué - KOB
The Working Group Bandages was established during the last ICC-Meeting in Vienna in May 2012.
Main working topic is currently the Stiffness of Bandages and how to measure it in vivo and in vitro.
The group is open for discussion around all matters related to the medical effectiveness and material
characteristics of Compression Bandages.
Michael Klöppels: Chairman
Wim De Klerk
The Working Group IPC (Intermittent Pneumatic Compression) was established in 2017 and is an open place to discuss all matters related to IPC, inter alia
Use of IPC in different Countries,
New fields of application,
Mobilisation of immobile patients,
IPC as supplement for bandages and stockings.
Meetings of the Working Group have been and will be organized in the framework of the ICC-Meetings and there are also “Inbetween-Discussions” by the Working Group Members.
Moderator/Chair of the Group is Dr. Michael Klöppels who is also a member of the Advisory Board of the ICC.